23 nuovi farmaci in commercio

Nuove specialitÓ medicinali:Celsentri, Elatrex, Tivicay, Tookad. 13 nuovi farmaci equivalenti

Nuove specialità medicinali
CELSENTRI 120 cpr riv 25 mg maraviroc
VIIV HEALTHCARE AIC:038138119 446,84€ H/RNRL in commercio dal:04/03/2019

CELSENTRI 120 cpr riv 75 mg maraviroc
VIIV HEALTHCARE AIC:038138121 1340,55€ H/RNRL in commercio dal:04/03/2019

CELSENTRI 1 flacone 230 ml 20 mg/ml maraviroc
VIIV HEALTHCARE AIC:038138133 685,17€ H/RNRL in commercio dal:04/03/2019

ELATREX 28 cpr 5 mg + 2,5 mg rilascio prolungato oxicodone cloridrato/naloxone cloridrato diidrato
MYLAN AIC:045870045 10,52€ A/RNR in commercio dal:15/03/2019

ELATREX 28 cpr 10 mg + 5 mg rilascio prolungato oxicodone cloridrato/naloxone cloridrato diidrato
MYLAN AIC:045870185 15,10€ A/RNR in commercio dal:15/03/2019

ELATREX 28 cpr 20 mg + 10 mg rilascio prolungato oxicodone cloridrato/naloxone cloridrato diidrato
MYLAN AIC:045870324 26,27€ A/RNR in commercio dal:15/03/2019

ELATREX 28 cpr 40 mg + 20 mg rilascio prolungato oxicodone cloridrato/naloxone cloridrato diidrato
MYLAN AIC:045870603 46,12€ A/RNR in commercio dal:15/03/2019

TIVICAY 30 cpr riv 10 mg dolutegravir sodio
VIIV HEALTHCARE AIC:043195039 180,16€ H/RNRL in commercio dal:04/03/2019

TIVICAY 30 cpr riv 25 mg dolutegravir sodio
VIIV HEALTHCARE AIC:043195054 450,41€ H/RNRL in commercio dal:04/03/2019

TOOKAD EV 1 flaconcino 366 mg padeliporfina potassico
STEBA BIOTECH S.A. AIC:045774027 20721,00€ Cnn / OSP in commercio dal:01/03/2019

Nuovi farmaci equivalenti
ALLOPURINOLO PENSA 50 cpr 100 mg allopurinolo
PENSA PHARMA AIC:044508012 1,25€ A/RR in commercio dal:04/03/2019

ALLOPURINOLO PENSA 30 cpr 300 mg allopurinolo
PENSA PHARMA AIC:044508024 2,05€ A/RR in commercio dal:04/03/2019

DARUNAVIR SANDOZ 60 cpr 600 mg darunavir
SANDOZ AIC:044715023 553,77€ H/RNRL in commercio dal:26/02/2019

DARUNAVIR SANDOZ 30 cpr 800 mg darunavir
SANDOZ AIC:044715035 364,53€ H/RNRL in commercio dal:26/02/2019

DARUNAVIR TEVA 60 cpr 600 mg darunavir
TEVA ITALIA AIC:044226823 553,77€ H/RNRL in commercio dal:27/02/2019

DARUNAVIR TEVA 30 cpr 800 mg darunavir
TEVA B.V. AIC:045028103 364,53€ H/RNRL in commercio dal:27/02/2019

LINEZOLID ACCORD HEALTHCARE 10 sacche 300 ml 2 mg/ml linezolid
ACCORD AIC:045707015 624,44€ H/OSP in commercio dal:27/02/2019

OLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE PENSA 28 cpr 20 mg + 12,5 mg olmesartan medoxomil/idroclorotiazide
PENSA PHARMA AIC:045129018 7,33€ A/RR in commercio dal:04/03/2019

OLMESARTAN MEDOXOMIL E IDROCLOROTIAZIDE PENSA 28 cpr 20 mg + 25 mg olmesartan medoxomil/idroclorotiazide
PENSA PHARMA AIC:045129020 7,33€ A/RR in commercio dal:04/03/2019

PRASUGREL MYLAN 28 cpr riv 5 mg prasugrel besilato
MYLAN AIC:046634010 39,68€ A/RR in commercio dal:05/03/2019

PRASUGREL MYLAN 28 cpr riv 10 mg prasugrel besilato
MYLAN AIC:046634022 39,68€ A/RR in commercio dal:05/03/2019

PRASUGREL TEVA 28 cpr riv 5 mg prasugrel bromidrato
TEVA B.V. AIC:045597186 39,68€ A/RR in commercio dal:28/02/2019

PRASUGREL TEVA 28 cpr riv 10 mg prasugrel bromidrato
TEVA B.V. AIC:045597402 39,68€ A/RR in commercio dal:28/02/2019